161 related articles for article (PubMed ID: 8930463)
21. De Novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival.
Herrero JI; Lorenzo M; Quiroga J; Sangro B; Pardo F; Rotellar F; Alvarez-Cienfuegos J; Prieto J
Liver Transpl; 2005 Jan; 11(1):89-97. PubMed ID: 15690541
[TBL] [Abstract][Full Text] [Related]
22. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
[TBL] [Abstract][Full Text] [Related]
23. [Melanoma in organ transplant patients].
Lévêque L; Dalac S; Dompmartin A; Louvet S; Euvrard S; Catteau B; Hazan M; Schollhamer M; Aubin F; Dreno B; Daguin P; Chevrant-Breton J; Frances C; Bismuth MJ; Tanter Y; Lambert D
Ann Dermatol Venereol; 2000 Feb; 127(2):160-5. PubMed ID: 10739973
[TBL] [Abstract][Full Text] [Related]
24. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
25. Human herpesvirus-8 infection and Kaposi's sarcoma after liver and kidney transplantation in different geographical areas of Spain.
García-Astudillo LA; Leyva-Cobián F
Transpl Immunol; 2006 Dec; 17(1):65-9. PubMed ID: 17157220
[TBL] [Abstract][Full Text] [Related]
26. [Renal graft survival in patients with systemic lupus erythematosus].
Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
[TBL] [Abstract][Full Text] [Related]
27. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
28. Obesity in renal transplantation: analysis of 2691 patients.
Cofán F; Vela E; Clèries M;
Transplant Proc; 2005 Nov; 37(9):3695-7. PubMed ID: 16386509
[TBL] [Abstract][Full Text] [Related]
29. Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study.
Tessari G; Naldi L; Boschiero L; Cordiano C; Piaserico S; Fortina AB; Cerimele D; La Parola IL; Capuano M; Gotti E; Ruggenenti P; Sassi F; Remuzzi G; Girolomoni G
Eur J Dermatol; 2006; 16(5):553-7. PubMed ID: 17101478
[TBL] [Abstract][Full Text] [Related]
30. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
31. Association of parental pretransplant psychosocial assessment with post-transplant morbidity in pediatric heart transplant recipients.
Stone D; Banerjee M; Dupuis J; Leleszi J; Allasio D; Singh TP
Pediatr Transplant; 2006 Aug; 10(5):602-7. PubMed ID: 16856997
[TBL] [Abstract][Full Text] [Related]
32. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients.
Knight RJ; Villa M; Laskey R; Benavides C; Schoenberg L; Welsh M; Kerman RH; Podder H; Van Buren CT; Katz SM; Kahan BD
Clin Transplant; 2007; 21(4):460-5. PubMed ID: 17645704
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for development of de novo neoplasia after liver transplantation.
Xiol X; Guardiola J; Menendez S; Lama C; Figueras J; Marcoval J; Serrano T; Botargues JM; Mañer M; Rota R
Liver Transpl; 2001 Nov; 7(11):971-5. PubMed ID: 11699033
[TBL] [Abstract][Full Text] [Related]
35. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
[TBL] [Abstract][Full Text] [Related]
36. Lymphocyte subsets and assessment of cancer risk in renal transplant recipients.
Ducloux D; Carron PL; Motte G; Ab A; Rebibou JM; Bresson-Vautrin C; Tiberghien P; Saint-Hillier Y; Chalopin JM
Transpl Int; 2002 Sep; 15(8):393-6. PubMed ID: 12221457
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients.
Andreoni M; Goletti D; Pezzotti P; Pozzetto A; Monini P; Sarmati L; Farchi F; Tisone G; Piazza A; Pisani F; Angelico M; Leone P; Citterio F; Ensoli B; Rezza G
J Infect; 2001 Oct; 43(3):195-9. PubMed ID: 11798259
[TBL] [Abstract][Full Text] [Related]
38. Tumors after renal and cardiac transplantation.
Penn I
Hematol Oncol Clin North Am; 1993 Apr; 7(2):431-45. PubMed ID: 8468275
[TBL] [Abstract][Full Text] [Related]
39. Kaposi's sarcoma in renal transplant patients: predisposing factors and prognosis.
Berber I; Altaca G; Aydin C; Dural A; Kara VM; Yigit B; Turkmen A; Titiz MI
Transplant Proc; 2005 Mar; 37(2):967-8. PubMed ID: 15848593
[TBL] [Abstract][Full Text] [Related]
40. Development and incidence of cancer following cyclosporine therapy.
Penn I; First MR
Transplant Proc; 1986 Apr; 18(2 Suppl 1):210-5. PubMed ID: 3515690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
